(Q33330195)

English

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma. (English)

1 reference

Europe PubMed Central

25 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Philip W. Kantoff

5

object named as

Kantoff PW

1 reference

Europe PubMed Central

25 July 2017

author name string

Oh WK

1

1 reference

Europe PubMed Central

25 July 2017

Manola J

2

1 reference

Europe PubMed Central

25 July 2017

Richie JP

3

1 reference

Europe PubMed Central

25 July 2017

Loughlin KR

4

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

25 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

25 July 2017

86

1 reference

Europe PubMed Central

25 July 2017

1329-1334

1 reference

Europe PubMed Central

25 July 2017

7

1 reference

Europe PubMed Central

25 July 2017

Metastatic bladder cancer: advances in treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Chemotherapy of urothelial tract tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Systemic chemotherapy of transitional cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Long-term results with M-VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete response

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1329%3A%3AAID-CNCR31%3E3.0.CO%3B2-R

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19991001)86:7<1329::AID-CNCR31>3.0.CO;2-R

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33330195&oldid=1773390449"